Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, January 31, 2024 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based d [...]
Trending Articles
More Pages to Explore .....